CTRI/2023/05/052526尚未招募Unknown
Efficacy of Thalidomide in combination with Hydroxyurea in patients of Sickle Cell Anaemia- A Randomised Control Trial
Dr Anindita Paul0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Written informed consent must be obtained prior to any screening procedures
- •2.Male patients aged 12 years and older and post menopausal female patients above 45 years on the day of signing informed consent.
- •3.Confirmed diagnosis of SCD by hemoglobin electrophoresis [performed in the hospital setting].
- •4.Patients with previous episodes of Vaso occlusive Crisis
- •5.Patients who havenâ??t been exposed to the use of HbF inducers other than HU
排除标准
- •1.Female patients of child bearing age group
- •( 15 -45years)
- •2.Patients with liver, renal, cardiac, pulmonary or neurological deficits
- •3.History of thrombotic episodes
- •4.Patient with active HIV infection (detectable viral load)
- •5.Patients with active Hepatitis B infection (HBsAg positive)
- •6.Positive test for hepatitis C infection
研究者
相似试验
尚未招募
4 期
Study the effects of combination of Thalidomide and Hydroxyurea in patients diagnosed with ThalassemiaCTRI/2024/07/071470Indian Council of Medical research [ICMR], New Delhi
尚未招募
3 期
se of medicines- Hydroxyurea and thalidomide for children suffering from thalassemiaCTRI/2023/12/060945ICMR, Delhi
进行中（未招募）
1 期
Phase II study of thalidomide in combination with temozolomide in metastatic malignant melanoma with brain metastases - Tem-ThalAdvanced metastic malignant melanomaEUCTR2004-005164-25-DKOdense University Hospital40
尚未招募
3 期
comparison of efficacy of tramadol hydrochloride versus linocaine hydrochloride as Local anesthetic and analgesic agent A single blind split mouth study.CTRI/2024/06/069607DR SHUBHAM DILIP PHADTARE
进行中（未招募）
1 期
Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infectioEUCTR2020-001605-23-ESBasque Health Service108